SCHEMBL4269263

SCHEMBL4269263

O=[N+]([O-])c1cccc(CCN(CCCl)CCCl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.61
SIGMAR1 Q99720 3/20 0.54
LMNA P02545 3/20 0.51
ALDH1A1 P00352 3/20 0.51
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
TDP1 Q9NUW8 1/20 0.45
POLB P06746 1/20 0.45
PYCR1 P32322 1/20 0.45
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PARP1 P09874 1/20 0.43
TRPV1 Q8NER1 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4934026 0.88 ALDH1A1 (0.65) TSHRSIGMAR1LMNAALDH1A1CYP1A2
SCHEMBL10553079 0.85 CYP2D6 (0.57) TSHRSIGMAR1LMNAALDH1A1CYP1A2
SCHEMBL365344 0.84 TSHR (0.73) TSHRSIGMAR1LMNAALDH1A1CYP1A2
SCHEMBL1734204 0.83 CYP1A2 (0.67) TSHRSIGMAR1LMNAALDH1A1CYP1A2
SCHEMBL10650109 0.83 CYP1A2 (0.67) TSHRSIGMAR1LMNAALDH1A1CYP1A2
SCHEMBL10551995 0.82 DRD2 (0.55) TSHRSIGMAR1LMNAALDH1A1CYP1A2
SCHEMBL4274526 0.81 KCNH2 (0.56) TSHRSIGMAR1CYP1A2CYP2C9CYP2C19
SCHEMBL1935375 0.81 TSHR (0.69) TSHRSIGMAR1LMNAALDH1A1CYP1A2
SCHEMBL3724067 0.80 SIGMAR1 (0.61) TSHRSIGMAR1LMNAALDH1A1CYP1A2
SCHEMBL10648914 0.79 CYP1A2 (0.74) TSHRSIGMAR1LMNAALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2036909-B1 QUATERNARY AMMONIUM SALT COMPOUNDS OF SPIROCYCLOPIPERAZINES, PREPARATION METHODS AND USES THEREOF UNIV BEIJING (CN) 2016-05-04 EP disclosed
US-9133195-B2 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof PEKING UNIVERSITY (CN) 2015-09-15 US disclosed
US-20090325929-A1 QUATERNARY AMMONIUM SALT COMPOUNDS OF SPIROCYCLOPIPERAZINES, PREPARATION METHODS AND USES THEREOF PEKING UNIVERSITY (CN) 2009-12-31 US disclosed
EP-2036909-A1 QUATERNARY AMMONIUM SALT COMPOUNDS OF SPIROCYCLOPIPERAZINES, PREPARATION METHODS AND USES THEREOF Peking University (CN) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325929-A1 QUATERNARY AMMONIUM SALT COMPOUNDS OF SPIROCYCLOPIPERAZINES, PREPARATION METHODS AND USES THEREOF CHRM4, CHRM1, CHRNA4 TSHR 170/4885SIGMAR1 27/4885LMNA 2494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.